Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017:2017:4894598.
doi: 10.1155/2017/4894598. Epub 2017 Jan 19.

Sulfated Glycans and Related Digestive Enzymes in the Zika Virus Infectivity: Potential Mechanisms of Virus-Host Interaction and Perspectives in Drug Discovery

Affiliations
Review

Sulfated Glycans and Related Digestive Enzymes in the Zika Virus Infectivity: Potential Mechanisms of Virus-Host Interaction and Perspectives in Drug Discovery

Vitor H Pomin. Interdiscip Perspect Infect Dis. 2017.

Abstract

As broadly reported, there is an ongoing Zika virus (ZIKV) outbreak in countries of Latin America. Recent findings have demonstrated that ZIKV causes severe defects on the neural development in fetuses in utero and newborns. Very little is known about the molecular mechanisms involved in the ZIKV infectivity. Potential therapeutic agents are also under investigation. In this report, the possible mechanisms of action played by glycosaminoglycans (GAGs) displayed at the surface proteoglycans of host cells, and likely in charge of interactions with surface proteins of the ZIKV, are highlighted. As is common for the most viruses, these sulfated glycans serve as receptors for virus attachment onto the host cells and consequential entry during infection. The applications of (1) exogenous sulfated glycans of different origins and chemical structures capable of competing with the virus attachment receptors (supposedly GAGs) and (2) GAG-degrading enzymes able to digest the virus attachment receptors on the cells may be therapeutically beneficial as anti-ZIKV. This communication attempts, therefore, to offer some guidance for the future research programs aimed to unveil the molecular mechanisms underlying the ZIKV infectivity and to develop therapeutics capable of decreasing the devastating consequences caused by ZIKV outbreak in the Americas.

PubMed Disclaimer

Conflict of interest statement

Vitor H. Pomin declares that there are no competing interests.

Figures

Figure 1
Figure 1
Structural representation of (a) heparan sulfate (HS) and (b) chondroitin sulfate (CS) and subtypes. (a) The repeating disaccharide unit of HS is composed of alternating 4-linked uronic acid and 4-linked α-glucosamine (GlcNX) units. The uronic acid can be either β-d-glucuronic acid (GlcA) as its major component or α-l-glucuronic acid (IdoA). Regarding possible substitutions, the GlcNX units are frequently N-acetylated (GlcNAc), occasionally N-sulfated (GlcNS), and rarely N-free (just the amino NH2 group, as GlcN). O-sulfation can occur at both units of HS. While 2-O-sulfation occurs occasionally at the IdoA, 6-O-sulfation is common at the GlcNS units. 3-O-sulfation may also occur at the occasional GlcNS6S unit but very rarely in terms of amounts. (b) The repeating disaccharide unit of CS is composed of alternating 4-linkedβ-d-glucuronic acid (GlcA) and 3-linked β-d-galactosamine (GalNAc) units. The CS subtypes differ according to sulfation patterns as follows: CS-A is mostly 4-O-sulfated at the GalNAc units, CS-C is predominantly 6-O-sulfated at the GalNAc units, CD-D is mostly 2-O-sulfated at the GlcA units and 6-O-sulfated at the GalNAc units, and CS-E is mostly 4,6-O-disulfated at the GalNAc units. In both panels, the glycosidic bonds are indicated inside the ellipses, whereas monosaccharide types are indicated inside the rectangles. For fast notation of the sulfation patterns, sulfation sites are highlighted by light-grey shadowed rectangles.

Similar articles

Cited by

References

    1. Brasil P., Calvet G. A., Siqueira A. M., et al. Zika virus outbreak in Rio de Janeiro, Brazil: clinical characterization, epidemiological and virological aspects. PLoS Neglected Tropical Diseases. 2016;10(4) doi: 10.1371/journal.pntd.0004636.e0004636 - DOI - PMC - PubMed
    1. Brasil P., Pereira J. P., Jr., Raja Gabaglia C., et al. Zika virus infection in pregnant women in Rio de Janeiro—preliminary report. The New England Journal of Medicine. 2016;375:2321–2334. - PMC - PubMed
    1. Calvet G. A., Filippis A. M. B., Mendonça M. C. L., et al. First detection of autochthonous Zika virus transmission in a HIV-infected patient in Rio de Janeiro, Brazil. Journal of Clinical Virology. 2016;74:1–3. doi: 10.1016/j.jcv.2015.11.014. - DOI - PubMed
    1. Cerbino-Neto J., Mesquita E. C., Souza T. M. L., et al. Clinical manifestations of zika virus infection, Rio de Janeiro, Brazil, 2015. Emerging Infectious Diseases. 2016;22(7):1318–1320. doi: 10.3201/eid2207.160375. - DOI - PMC - PubMed
    1. Heukelbach J., Alencar C. H., Kelvin A. A., de Oliveira W. K., de Góes Cavalcanti L. P. Zika virus outbreak in Brazil. Journal of Infection in Developing Countries. 2016;10(2):116–120. doi: 10.3855/jidc.8217. - DOI - PubMed

LinkOut - more resources